USSTOCK.TODAY
Market Closed
Log in Sign up

Cathie Wood buys CRISPR Therapeutics shares for two consecutive days

The Motley Fool +1 · ·by G4L

CRSP
CRSP CRISPR Therapeutics AG
$40.37 -4.43%
View chart & analysis →
  1. 1Cathie Wood purchased $1.1 million in shares on Friday, October 9.
  2. 2Cathie Wood purchased $2.3 million in shares on Monday, October 12.
  3. 3CRISPR Therapeutics recorded $76 million in Casgevy revenue for the second quarter.

So what's the key point?

Cathie Wood bought CRISPR Therapeutics shares over two days. CRISPR Therapeutics generated $76 million in revenue during the second quarter.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →